The GSEA and IPA analysis revealed 23 enriched genes including PDIA4, HDAC1, and MDM2 with higher mutation accumulation scores in the effusion-associated DLBCL samples versus the comparison cohort. The gene discussed is HDAC1; the disease is diffuse large B-cell lymphoma.